Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-008570
Filing Date
2017-08-07
Accepted
2017-08-07 06:16:32
Documents
39
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 210535
2 ex1-1.htm EX-1.1 14223
3 ex2-1.htm EX-2.1 8434
4 ex3-1.htm EX-3.1 263511
  Complete submission text file 0001493152-17-008570.txt   1671035

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE oti-20170630.xml EX-101.INS 160074
6 XBRL SCHEMA FILE oti-20170630.xsd EX-101.SCH 22926
7 XBRL CALCULATION FILE oti-20170630_cal.xml EX-101.CAL 23281
8 XBRL DEFINITION FILE oti-20170630_def.xml EX-101.DEF 68075
9 XBRL LABEL FILE oti-20170630_lab.xml EX-101.LAB 162661
10 XBRL PRESENTATION FILE oti-20170630_pre.xml EX-101.PRE 118424
Mailing Address 233 NEEDHAM STREET SUITE 300 NEWTON MA 02464
Business Address 233 NEEDHAM STREET SUITE 300 NEWTON MA 02464 617-454-1199
Oxygen Therapy, Inc. (Filer) CIK: 0001685616 (see all company filings)

EIN.: 812723728 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-214306 | Film No.: 171009923
SIC: 2834 Pharmaceutical Preparations